Sheehy Christine Elise has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 1000 shares of Coeptis Therapeutics Holdings, Inc. ($COEP) on February 11, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Sheehy Christine Elise | VP Compliance and Secy | M | Common stock | 1000 | $10.56 | 64,031.0000 | 4,745,089 | 1.59% | 0.02% |
| Feb. 11, 2026 | Coeptis Therapeutics Holdings, Inc. | $COEP | Sheehy Christine Elise | VP Compliance and Secy | A | Common Stock | 12500 | $0.00 | 64,031.0000 | 4,745,089 | 24.26% | 0.26% |
| March 4, 2025 | Coeptis Therapeutics Holdings, Inc. | $COEP | Sheehy Christine Elise | VP Compliance and Secy | A | Non-Qualified Stock Options (right to buy) | 1000 | $0.00 | 13,500.0000 | 1,924,639 | 8.00% | 0.05% |
| Jan. 27, 2023 | Coeptis Therapeutics Holdings, Inc. | $COEP | Sheehy Christine Elise | CFO and Secretary | A | Incentive Stock Options (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |